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Abstract Here we have developed protocols using the baboon as a complementary alternative Old World Primate to rhesus
and other macaques which have severe limitations in their availability. Baboons are not limited as research resources, they
are evolutionarily closer to humans, and the multiple generations of pedigreed colonies which display complex human
disease phenotypes all support their further optimization as an invaluable primate model. Since neither baboon-assisted
reproductive technologies nor baboon embryonic stem cells (ESCs) have been reported, here we describe the first derivations
and characterization of baboon ESC lines from IVF-generated blastocysts. Two ESCs lines (BabESC-4 and BabESC-15) display
ESC morphology, express pluripotency markers (Oct-4, hTert, Nanog, Sox-2, Rex-1, TRA1-60, TRA1-81), and maintain stable
euploid female karyotypes with parentage confirmed independently. They have been grown continuously for N430 and
290 days, respectively. Teratomas from both lines have all three germ layers. Availabilities of these BabESCs represent
another important resource for stem cell biologists.
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179Derivation of baboon embryonic stem cellsIntroduction
Nonhuman primates and embryonic stem cells derived from
nhps (nhpESCs) have contributed significantly to the transla-
tion of mouse stem cell findings to humans. For example, the
establishment of nhpESCs (Thomson et al., 1995, 1996)
provided the experimental foundation and biomedical ratio-
nale for the derivations of human ESCs 3 years later (Thomson
et al., 1998). Innovative discoveries with nhpESCs continue to
provide experimental evidence in support of hESC investiga-
tions (Friedrich Ben-Nun and Benvensity, 2006; Shufaro and
Reubinoff, 2004; Dvash and Benvenisty, 2004). Parthenoge-
netic nhpESCs (Cibelli et al., 2002a) preceded the generation
of parthenogenetic human ESCs (Lin et al., 2007; Mai et al.,
2007; Revazova et al., 2007), which are of great utility
notwithstanding the findings that they are unlikely to be exact
immune matches to the female donor (Dighe et al., 2008).
Therapeutic cloning has now succeeded in rhesus (Byrne et al.,
2007; Cram et al., 2007), inspiring encouraging advances in
humans (French et al., 2008) beyond previous credible
attempts (Cibelli et al., 2002b; Lavoir et al., 2005; Stojkovic
et al., 2005). Now, evaluating the clinical utility of stem cells
generated by induced pluripotency (iPS) as well as direct
differentiation (Zhou et al., 2008) is of keen importance.
Nonhuman primate ESCs are accelerating mechanistic dis-
coveries of diseases, e.g., nhpESCs as Alzheimer's disease
models (Wianny et al., 2008). Transplantation of differentiated
nhpESCs into primate models of Parkinson's disease (Takagi
et al., 2005) and other disorders (Hematti et al., 2005) is
providing encouraging preclinical results on the feasibility of
stem cell therapies in clinical regenerativemedicine, as shown
in rodent models (Ben-Hur et al., 2004). Macaques, which
include both rhesus (Mitalipov et al., 2006; Navara et al., 2007;
Thomson et al., 1995) and cynomolgus (Suemori and Nakatsuji,
2006), represent the only family of OWPs from which nhpESCs
have been established [reviewed by (Wilmut and Taylor,
2007)], though ESCs from the New World marmoset have also
been derived (Thomson et al., 1996; Sasaki et al., 2005).
Notwithstanding the admirable contributions of macaque
ESCs to translational and fundamental biology, several crucial
questions about hESC biology which could be solved with
nonhuman primates have not been answered using the
available nhp stem cell lines. These questions include: Are
primate ESCs pluripotent when investigated using ideally
intraspecific or even interspecific chimera assays? Will they
contribute to the germ line? Will pluripotent primate ESCs
engraft anddifferentiateproperlywhen transplanted into fetal
or adult primates? Will they be rejected or will they generate
teratomas or other tumors? Will primate cells generated by iPS
behave similar to nhpESCs derived from embryos generated by
IVF or somatic cell nuclear transfer (SCNT)? There are several
reasons that these questions have not yet been solved,
including severe limits in resource availability, cost, generation
time, and lack of pedigreed lineages, as well as possible
limitations in the nhpESCs currently available.
Results
Baboon (Papio anubis) embryos were produced by ICSI
and cultured in vitro for 8–12 days postinsemination.
Eleven females generated 157 successfully fertilized oocytes
Figure 1 Derivation of baboon embryonic stem cell lines, BabESC-4 and BabESC-15. (A, B) Baboon blastocysts produced from ICSI
zygotes cultured in vitro for 9 days (arrows: prominent inner cell masses). (C, D) Day 8 post-ICM plating, showing rapid expansion of both
nascent cell lines in culture. (E, F) Colony growth observed after the first mechanical passage ~Days 18–19 post-ICM plating. (G, H) Both
baboon cell lines have colonies demonstrating definitive morphological characteristics of embryonic stem cells, including large nuclear-
to-cytoplasmic ratios, tightly packed cells with prominent nucleoli, and distinct colony borders. (I, J) BabESC colonies at 182 and 42 days
postplating, respectively. Left column: BabESC-4. Right column: BabESC-15. Bar: 20 μm; (C–J) ×100 inverted phase contrast optics.
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Figure 2 RT-PCR analysis of pluripotency markers in baboon
ESC lines. Baboon ES colonies with good morphology were
scraped, RNA was isolated, and reverse transcriptase PCR was
performed using the primers described under Materials and
methods. Results indicated expression of POU5F1 (Oct-4;
577 bp), hTERT (280 bp), Nanog (150 bp), Sox-2 (488 bp), and
Rex-1 (350 bp). Negative controls included no template and no
RT, both negative (not shown). BabESC-4, Lanes 1, 3, 5, 7, 9;
BabESC-15, Lanes 2, 4, 6, 8, 10.
181Derivation of baboon embryonic stem cells(Table 1), from which 19 expanded blastocysts (11%) were
produced. Their inner cell masses (ICMs) were isolated by
immunosurgery and plated onto inactivatedmouse embryonic
fibroblasts (MEFs). Sixteen (84%) ICMs plated within the first
48–72 h postisolation, with 15 (79%) surviving at least 1 week,
and 2 lines (11%) expanding in culture by 1 month (Table 1).
Both surviving lines were derived from Day 9 blastocysts.Figure 3 Immunocytochemical analysis of pluripotency markers f
lines BabESC-4 and BabESC-15 express the nuclear transcription facto
BabESC-15) as well as the cell surface markers TRA-1-60 (I, BabESC-4)
L. Bars=20 μm.The establishment of BabESC-4 and BabESC-15 cell lines is
shown in Fig. 1. The Day 9 expanded blastocysts exhibit
prominent ICMs (Figs. 1A and B) that attach onto inactivated
MEF feeders within 48 h after immunosurgery. Visible
colonies are apparent by Day 8 post-ICM plating (Figs. 1C
and D), and expand in culture over 2 weeks. Both ESC
colonies demonstrate typical ESC appearances, i.e., tightly
packed cells with well-defined borders, large nuclear-to-
cytoplasmic ratios, and prominent nucleoli (Figs. 1E–H).
BabESC-4 has been continuously cultured for N431 days (Fig.
1I) while the BabESC-15 line has been in culture for N292 days
(Fig. 1J). Mechanical passaging of selected colonies deemed
of good morphology, performed weekly, maintains and
propagates both cell lines. Both BabESC-4 and BabESC-15
have been cryopreserved and thawed, and colonies were
successfully reestablished in vitro (Supplemental Table 1).
Baboon ESC characterization: In vitro assays
The established BabESC-4 and BabESC-15 cell lines demon-
strate known “stemness” markers as determined both RT-
PCR and immunocytochemistry (ICC) analyses (Figs. 2 and 3,
respectively). RT-PCR with specific primers detected tran-
scripts of the correct size for hTERT, Oct-4(POU5F1), Nanog,
Rex-1, and Sox-2 in both BabESC-4 and BabESC-15 (Fig. 2),
but did not detect transcripts in baboon fibroblast cells lines
(Supplemental Fig. S1). Antibodies recognizing Oct-4 and
Nanog demonstrate specific nuclear localization in coloniesor BabESC-4 and BabESC-15. (A–H) Baboon embryonic stem cell
rs Oct-4 (A, BabESC-4; E, BabESC-15) and Nanog (C, BabESC-4; G,
and TRA-1-81(J, BabESC-4). Hoechst DNA: panels B,D, F,H, J, and
182 C.R. Simerly et al.of BabESC-4 (Figs. 3A–D) and BabESC-15 (Figs. 3E–H)
following ICC staining analysis. Likewise, the conserved cell
surface pluripotent markers Tra-181 and Tra-160 are also
identified in BabESC-4 (Figs. 3I–L) and BabESC-15 (Supple-
mental Fig. S2). Labeling of these two cell surface markers
required different fixation protocols than those for human or
rhesus ESC lines, perhaps suggesting epitope differences.
The primate specific cell surface marker SSEA-4 was weaker
on both baboon cell lines than those identified on macaque
or human colonies, but still positive (Supplemental Fig. S2).
Interestingly, SSSEA-4 staining in early baboon embryos was
also weakly detected in the trophectoderm and ICM, perhaps
for the reasons identified above (Supplemental Figs. S2D–G).
Supplementary Table 1 summarizes the comparison of
specific stemness and cell surface marker antibodies among
baboon, macaque, and human lines.
Both BabESC-4 and BabESC-15 display normal female
diploid cell line karyotypes with 20 autosomes and two female
sex chromosomes, even when continuously cultured for N1
year (Figs. 4A and C, BabESC-4; Figs. 4B and D, BabESC-15).
The pedigrees of BabESC-4 and BabESC-154 were also
independently confirmed with DNA fingerprinting analysis
with the presumptive gamete donors (Supplemental Table 2).
Teratoma assays and baboon ESC characterization
by in vitro differentiation
Fig. 5 demonstrates differentiation into each of the three
germ layers for BabESC-4. Figs. 5A and 5B show multipleFigure 4 Karyotypes of BabESC-4 and BabESC-15 cell lines by Giem
panel C, passage 53, Day 370) and BabESC-15 (panel B, passage 6, Da
lines, with 20 autosomal pairs and 2 female sex chromosomes.tissue types from the three germ layers, e.g., gastrointest-
inal tissue, cartilage, and skin. Ectoderm derivatives,
including retinal pigment, were observed (Figs. 5C and
5D). Mesoderm is in Figs. 5E and 5F, e.g., striated muscle
(Fig. 5E) and cartilage undergoing ossification (Fig. 5F).
Endodermal derivatives like respiratory ciliated epithelium
organizing a tracheal–bronchiolar structure (Fig. 5G) and
early development of gastrointestinal tissue (Fig. 5H) were
observed.
The pluripotency of BabESC-15 has been established by
the generation of a teratoma and by spontaneous differ-
entiation of colonies in vitro (Supplemental Fig. S3). We
identified prominent ectoderm and mesodermal germ lines
in a single teratoma following tissue sectioning (Fig. S3A–D).
Ectoderm derivatives included early brain development (Fig.
S3A), mature brain tissue with pigmented cells (Fig. S3B; pc,
arrows), and classical choroid plexus tissue (Fig. S3C).
Mesoderm derivatives were identified as cartilage (Fig.
3SD; ca) with adjacent areas of choroids plexus (Fig. S3D;
cp) and pigmented cells (Fig. S3D; pc, arrow) observed.
Evidence of early gastrointestinal tissue (endoderm) was
observed but not yet fully confirmed (our unpublished
observation).
Alteration of the feeder cells to STOs on a modified stem
cell medium containing no hLIF, Activin A, and reduced bFGF
(4 ng/ml) permitted BabESC-15 cells to differentiate within 2
weeks. Some colonies expressed cytokeratin-11, an ecto-
dermal lineage marker of differentiation (Fig. S3F, green),
while others appear as differentiated neuronal cellssa chromosomal banding. BabESC-4 (panel A, passage 4, Day 30;
y 40; and panel D, p35, Day 235) are both normal female diploid
Figure 5 BabESC-4 teratoma differentiation into all three germ layers. (A, B) All three germ layers were present. ne,
neuroectoderm; gi, gastrointestinal tissue; ca, cartilage. (C, D) Ectoderm, e.g., retinal pigment (C: pc, arrow), skin (D: sk, arrow), and
hair follicle (D: hf, arrow). (D) muscle (ms, arrow). (E, F) Mesoderm, e.g., striated muscle (E: ms, arrow) and cartilage (F; ca, arrow).
(F) Pr, periostium; gi, gastrointestinal tissue. (G, H) Endoderm, e.g., respiratory ciliated epithelium (G: re, arrow) and gastrointestinal
epithelium (H: gi, arrow). (G) Muscle, ms, arrow; cartilage, cs, arrow. Magnifications: (A, B) ×4; (C) ×40; (D) ×10; (E, F) ×40; (G,H) ×20.
183Derivation of baboon embryonic stem cellsprominently expressing β-III tubulin (Fig. S3G, red; Fig. S3E,
DNA, blue; merged image, Fig. S3H).
Discussion
The derivation and characterizations of baboon PSCs here
have several biomedical justifications including providing an
OWP research resource for translational medicine withcharacteristics either complementary or superior to maca-
ques. Baboons are the closest human relatives among the
OWP; they are extensively studied in transplantation
research since their physiology, size, and organ compatibil-
ities more closely model human conditions, and they have
been extensively pedigreed for genetic and environmental
parameters which generate complex disease phenotypes
including diabetes, heart disease, and obesity. Their size and
184 C.R. Simerly et al.relative docility support noninvasive MRI imaging studies of
postimplantation development as well as tracking the fates
of transplanted PSCs. Macaques, and especially certain
strains of rhesus macaques (e.g., MaMu), are used exten-
sively for invaluable HIV-AIDS studies (Braun and Johnson,
2006). Finally, baboons represent a preclinical research
resource that is readily available and relatively cost-
effective to complement the nearly inexhaustible demands
on macaques.
Baboon ESCs join the rhesus and cynomolgus ESCs in
expressing pluripotency markers identical to hESCs (e.g.,
Oct-4, Nanog, Rex, hTert) and unlike mouse ESCs (e.g., not
SSEA-1; Laslett et al., 2003). They form all three germ layers
in teratomas, grow continuous in culture after extensive
numbers of passages, display stable diploid karyotypes, and
differentiate in vitro. Genetic pedigree analysis permits
independent confirmations of accuracy for quality control,
which is not possible with anonymously donated hESCs.
Genetic and immunological matching after transplantation is
enabled due to the availability of parents of these lines and
also to the ability to generate full-sibling offspring for
further investigations.
Pluripotent stem cells from NHPs have been obtained
from macaques and marmosets, and now here in baboons. A
consideration of NHP diversity is worthwhile as well as
evaluations of their potential contributions for regenerative
studies. Nonhuman primates include apes (greater apes such
as chimpanzees, gorillas, and orangutans; lesser apes such as
gibbons), OWPs (e.g., macaques, baboons, vervet, or green
monkeys), new world monkeys (NWP; e.g., marmosets,
capuchins, spider, squirrel, and owl monkeys), and the
prosimians such as lemurs. Notwithstanding their genetic
proximity to humans and the sequencing of the chimpanzee
genome (Culotta, 2005; Pennisi, 1995; Wildman, 2002),
investigations with apes are restricted appropriately, though
rationales for establishing ape PSCs include important
neuroprogenitors, “-omics” comparisons, and immunological
and infectious disease research rationales. On the other end
of the spectrum, prosimian stem cells might offer interesting
resources for taxonomic and evolutionary biologists. Because
the primary justifications for NHP research are fundamental
biology and translational medicine, PSCs from OWPs and
NWPs can be predicted to continue to generate the greatest
dividends based on research investments. Among the NWPs,
marmoset stem cell research has led to the first ESC lines
(Thomson et al., 1996), as well as interesting transplantation
studies (Iwanami et al., 2005; Oka et al., 2004). However,
because of genetic commonality among OWPs and humans,
as well as the enormous experimental resources established
especially for macaques, OWPs are likely to remain as the
most prominent NHP models for PSC studies. PSCs have been
established from rhesus (Mitalipov et al., 2006; Navara et al.,
2007; Thomson et al., 1995) and cynomolgus (Suemori and
Nakatsuji, 2006; Vrana et al., 2003), and, in personal
communications, pig-tail (Hayes, 2008) macaques. Also,
important findings regarding PSCs have been reported for
differentiation (Boyd et al., 2008; Elkabetz et al., 2008;
Kawasaki et al., 2002a; 2002b; Mizuseki et al., 2003;
Nakatsuji et al., 2008; Stadtfeld et al., 2008; Trounson,
2006; Vaca et al., 2006); therapeutic improvements after
transplantation (Takagi et al., 2005; Takahashi, 2006);
histocompatability assays (Dighe et al., 2008; Rajesh et al.,2007); and epigenetics (Fujimoto et al., 2005, 2006;
Mitalipov et al., 2007; Mitalipov, 2006; Rugg-Gunn et al.,
2005a, 2005b, 2007; Zhang et al., 2007) (Brons et al., 2007).
Both the baboon ESC lines presented here and the rhesus
ESCs differ in certain growth characteristics from hESCs, and
slight modifications of culture conditions are employed.
From our experience in growing human and nhp lines side-by-
side in the laboratory, the nhpESCs lines appear to have
stricter requirements on feeder layer density in order to
maintain compact colony morphology and well-defined
borders (~26 000 cells/cm2 for nhps versus 40–60 000
cells/cm2 for humans). Also, nhpESCs require greater
adherence to passage time (7–8 days maximum) compared
to hESCs and manual passaging methods are required.
Notwithstanding these minor differences, they are far more
similar to hESCs than mouse ESCs, and therefore represent an
important translational resource.
In conclusion, here we describe the derivation and
characterizations of embryonic stem cell lines from pedi-
greed baboon embryos. The babESCs display stringent
criteria, including long-term self-renewal and pluripotency
as demonstrated in teratoma assays as well as in vitro
differentiation and by expression of pluripotency molecular
markers. Early passages have been banked and independent
genetic testing confirms identity. Because baboons are
investigated extensively in transplantation research and
because, unlike rhesus macaques, they are readily available
for responsible investigations, these new baboon embryonic
stem cells are proposed to represent another important
resource in the armamentarium for stem cell biology.
Materials and methods
Regulations
All experiments involving animals were approved by the
Institutional Animal Care and Use Committees (IACUCs) from
the Southwest National Primate Research Center of the
Southwest Foundation for Biomedical Research, the Magee-
Womens Research Institute, and the University of Pittsburgh.
Also, this work complies with NIH Guidelines for Research
Involving DNA Molecules under the direction of the University
of Pittsburgh Institutional Biosafety Committee. All work
with lentivirus and lentivirus-transduced cells complied with
BLS-2+laboratory practices.
Baboon-assisted reproductive technology (ART)
Embryos were generated in vitro from gametes obtained
from fertile baboons using ICSI, and developed to the
blastocyst stage as modified (Hewitson et al., 1998). Briefly,
hyperstimulation of female baboons was started on Days 1–2
of menses onset by a single daily subcutaneous injection of
0.25 μg/ml gonadotropin-releasing hormone (GnRH) antago-
nist (Antide; Ares Serono, Randolph, MA), 60 IU recombinant
human follicle stimulating hormone (r-FSH; Organon, Inc.,
West Orange, NJ), and 60 IU recombinant human luetinizing
hormone (r-HLH; Organon). A final intramuscular injection of
5000 IU of recombinant human chorionic gonadotropin (r-
hCG; Serono) was administered on Day 10 and mature
follicles were aspirated by laparoscopy 30 h post-hCG as
185Derivation of baboon embryonic stem cellspreviously reported (Bavister et al., 1983). Mature oocytes
were fertilized by intracytoplasmic sperm injection (ICSI)
(Hewitson et al., 1998) using motile sperm separated on a
PureCeption sperm gradient (Sage In-Vitro Fertilization, Inc.,
Trumbull, CT) as described by the manufacturer. Fertilization
success was defined as zygotes with 2 polar bodies and 2
pronuclei. Culture to the expanded blastocyst stage was
accomplished in CMRL-1066 medium (Boatman, 1997) with
10% fetal calf sera (Hyclone Laboratories, Inc., Logan, UT) on
monolayers of buffalo rat liver cells (BRL 1442; American
Type Culture Collection, Rockville, MD).
Baboon embryonic stem cell derivations
Inner cell mass cells were isolated from expanded blastocysts
using immunosurgery (Navara et al., 2007). ICMs were plated
onto mitomycin C-treated mouse embryonic fibroblasts
(MEF; Chemicon, Millipore Corporation, Billerica, MA) in
80% Knockout Medium; 20% Knockout Serum Replacement;
1 mM L-glutamine; 0.1 mM nonessential amino acids; 1%
penicillin/streptomycin; 12 ng/ml of bFGF; 10 ng/ml of
Activin A and 10 ng/ml hLIF (all components from Invitrogen
[Carlsbad, CA] except hLIF [Chemicon] and Activin A [Sigma])
(Navara et al., 2007). After 10–14 days, established colonies
of ESCs were mechanically passaged onto new MEFs for
expansion with culture medium changed every 48 h.
Pluripotency markers detected by
immunocytochemistry
Putative baboon ESCs were assayed for the standard pluripo-
tency markers (Oct-4, Nanog, SSEA-1, SSEA-4, Tra 1-60, and Tra
1-81) on undifferentiated colonies after fixation by 2%
paraformaldehyde (Electron Microscopy Services, Hatfield, PA)
in PBS for 40 min or absolute methanol (-20 °C; 10 min; Sigma;
Navara et al., 2007). Control cell staining included differen-
tiated colonies and baboon primary fibroblast lines which were
consistently negative. Baboon embryos from the 8-cell stage to
early arrested blastocysts were fixed as above after removal of
the zona pellucida with brief acid Tryode's incubation. Primary
antibodies were added overnight at 4 °C and secondary
antibodies applied for 1 h at 37 °C after extensive washing in
PBS+0.5% goat serum. DNA was detected with Hoechst 33342
added in the penultimate PBS rinse for 5min beforemounting in
antifade (Vectashield; Vectors Lab, Burlingame, CA).
Pluripotency markers detected by RT-PCR
Pluripotent BabESCs were collected by scraping and pelleted at
200 g for 5 min. RNA was isolated using Trizol (Invitrogen) and
cDNA was prepared using the Improm-II Reverse Transcription
System (Promega, Madison WI) according to the manufacturer's
directions. Primers used were hTERT, forward gtgtgctgcagctcc-
catttc and reverse gctgcgtctgggctgtcc, Oct-4, forward cgac-
catctgccgctttgag and reverse ccccctgtcccccattccta, Nanog
forward ctgtgatttgtgggcctgaa and reverse tgtttgcctttgggactggt,
Rex1 forward gcgtacgcaaattaaagtccaga and reverse cagcatcc-
taaacagctcgcagaat, and Sox-2, forward cccccggcggcaatagca
and reverse tcggcgccggggagatacat. Baboon skin fibroblast cells
and rhesus pluripotent ES cells (line 4706; Navara et al., 2007)
were run as controls.Pluripotency demonstrated in teratomas
Approximately 5×105–5×106 baboon ESC cells of good
morphology were injected into the testis of 8- to 12-week-
old NOD-SCID mice (Jackson Labs) using a sterile 31 G needle
to produce teratomas (Navara et al., 2007). Tumor growths
were determined by palpation at approximately 10–12
weeks after injection, excised, and fixed in 4% paraformal-
dehyde prior to paraffin embedding. Sections were stained
with hematoxylin and eosin.
Directed in vitro differentiation
BabESCs were plated into a 6-well tissue culture plates (Fisher
Scientific, Pittsburgh, PA) with STO feeders in a modified
embryonic stem cell medium composed of 80% Knockout
DMEM, 20% Knockout Serum Replacement, 1 mM L-glutamine,
0.1mMNEAA, 1% Pen/Strep , 4 ng/ml bFGF65–68. Colonieswere
fed every other day. After 2 weeks, colonies were fixed in 2%
formaldehyde and immunostained using primary antibodies to
cytokeratin-11 (1: 200; Abcam, Cambridge, MA) and beta-III
tubulin (1: 200; Covance, Berkeley, CA).
ESC cytogenetic characterization
Slides with prepared BabESCs were banded using trypsin and
Giemsa stains (Barch, 1997). Metaphase spreads were
analyzed with the Cytovision Workstation and Genus image
processing software (Applied Imaging, Grand Rapids, MI) to
arrange baboon chromosomes into matching pairs (Pearson
et al., 1979). A routine mitotic cell count was 20 metaphases,
analyzing chromosomes band by band in 3 cells, 2–3 photos,
and 2–3 karyotypes (American College of Medical Genetics,
2006). We performed karyotype analysis on continuous
cultures at the following passage and days postplating:
BabESC-4, passage 4, Day 30, and passage 53, Day 370;
BabESC-15, passage 6, Day 40, and passage 35, Day 235.
Independent external genetic testing for
pedigreed confirmations
DNA genotyping was performed independently at the
Veterinary Genetics Laboratory, University of California–
Davis under the direction of Dr. Cecelia Penedo (Supple-
mental Table 2).
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